Cancer Core Europe (CCE) Lecture: Image - based AI for precision screening (Fredrik Strand)

Abstract
Until recently, mammography screening has retained the same basic design as in the 1990s. Now, advances in artificial intelligence (AI) offer opportunities for major improvements – in reducing the radiologist workload and in detecting more breast cancers early. Since 2019, there have been many retrospective observational studies where AI models have been trained and tested using mostly case-control study designs. Last year, 2023, we saw the first clinical interventional trials, including ScreenTrustCAD from our group at Karolinska Institutet, which was the first to start in population-wide screening. In this presentation, we will describe findings from retrospective studies, highlight issues related to proper validation of AI models and discuss key findings from the latest prospective studies on AI for breast cancer screening.

What is Cancer Core Europe (CCE)?
Cancer Core Europe is a consortium of seven leading cancer centres (www.cancercoreeurope.eu). CCEs members are driven by a strong will to reshape the cancer research model to ultimately increase the European Union’s competitiveness as a place to conduct cutting-edge research that’s translated to the clinic to deliver more personalized medicine.

What is the content and aim of the CCE Lecture?
The CCE Lecture series is a CCE-internal event, which educates and informs about state-of-the-art research within the seven centers and is aimed to increase awareness among partners about each other’s activities and potential for collaboration

Link for Zoom